Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
12
×
fda
12
×
life sciences
national blog main
clinical trials
boston blog main
boston top stories
san francisco blog main
san diego blog main
san diego top stories
san francisco top stories
deals
detroit blog main
detroit top stories
investing
national top stories
new york blog main
raleigh-durham blog main
boston
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
ipo
new york top stories
raleigh-durham top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
medical device
medical devices
national
biofourmis
black diamond therapeutics
chronic kidney disease
What
therapeutics
12
×
drug
ipo
medicines
million
new
raised
treat
approved
companies
company
developing
fda
bio
biotech
black
cancer
debut
diamond
disease
immunotherapy
late
leading
life
momentum
public
rare
roundup
science
therapy
week
affects
agency
aimmune
allergy
allogene
americans
analytics
approval
awarded
Language
unset
Current search:
fda
×
biotech
×
therapeutics
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed